|
PTPRK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.17019999982205E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5876002169033E-10 |
| Normal-vs-Stage2 |
2.410300E-02 |
| Normal-vs-Stage3 |
3.938500E-02 |
| Normal-vs-Stage4 |
2.584000E-01 |
| Stage1-vs-Stage2 |
1.173560E-01 |
| Stage1-vs-Stage3 |
5.50120000000209E-05 |
| Stage1-vs-Stage4 |
2.792100E-04 |
| Stage2-vs-Stage3 |
3.291800E-01 |
| Stage2-vs-Stage4 |
1.836360E-01 |
| Stage3-vs-Stage4 |
5.684400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.84809999987424E-07 |
| Normal-vs-AfricanAmerican |
3.560200E-02 |
| Normal-vs-Asian |
1.274390E-01 |
| Caucasian-vs-AfricanAmerican |
6.094200E-01 |
| Caucasian-vs-Asian |
4.990800E-01 |
| AfricanAmerican-vs-Asian |
4.442000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.9416999999986E-05 |
| Normal-vs-Female |
8.77159999967958E-07 |
| Male-vs-Female |
1.707160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.052840E-01 |
| Normal-vs-Age(41-60Yrs) |
2.73679999995835E-07 |
| Normal-vs-Age(61-80Yrs) |
1.201790E-04 |
| Normal-vs-Age(81-100Yrs) |
6.232000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.701200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.889600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.842400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.046370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.167800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.831240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.217600E-03 |
| Normal-vs-Grade 2 |
3.56650264876635E-11 |
| Normal-vs-Grade 3 |
4.519400E-03 |
| Normal-vs-Grade 4 |
6.486200E-01 |
| Grade 1-vs-Grade 2 |
1.343180E-01 |
| Grade 1-vs-Grade 3 |
3.619700E-02 |
| Grade 1-vs-Grade 4 |
7.017700E-03 |
| Grade 2-vs-Grade 3 |
1.69182999999462E-05 |
| Grade 2-vs-Grade 4 |
1.31430000216426E-09 |
| Grade 3-vs-Grade 4 |
6.217300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72595271408227E-12 |
| Normal-vs-ccB subtype |
4.100100E-02 |
| ccA subtype-vs-ccB subtype |
3.16229999963724E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68119999999217E-06 |
| Normal-vs-N1 |
9.872800E-01 |
| N0-vs-N1 |
7.272100E-02 |
|
|
